Cromwell Holdings’s Exact Sciences EXAS Stock Holding History

Cromwell Holdings’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-32	Closed	-$3.25K	–	1044
2025 Q4	$3.25K	Hold	32	–	–	﹤0.01%	643
2025 Q3	$1.75K	Hold	32	–	–	﹤0.01%	723
2025 Q2	$1.7K	Buy	32 +16	+100%	+$813	﹤0.01%	719
2025 Q1	$693	Buy	+16	New	+$810	﹤0.01%	710

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Cromwell Holdings's EXAS Position: Q1 2026 in Review

Cromwell Holdings sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 32 shares — an estimated $3.25K sold.

Cromwell Holdings first reported a position in EXAS in Q1 2025 and held it in 4 quarters. The position peaked at $3.25K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Cromwell Holdings reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Cromwell Holdings sold 32 Exact Sciences shares in Q1 2026, an estimated $3.25K.
Cromwell Holdings first reported a position in Exact Sciences in Q1 2025 and held it in 4 quarters.
Cromwell Holdings's Exact Sciences position peaked at $3.25K in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Cromwell Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.